Emergency Management of Adverse Events From Cancer Immunotherapy: Downloadable Slides

Review key recommendations on identification, assessment, and management of immune-related adverse events associated with immune checkpoint inhibitor therapy in the emergency department setting.
John Thompson Headshot
John A. Thompson, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 4.93 MB
Released: May 20, 2019


Provided by National Comprehensive Cancer Network.

Karen Kanefield
Manager CE Accreditation & Program Operations
National Comprehensive Cancer Network
3025 Chemical Road, Suite 100
Plymouth Meeting, PA 19462

215-690-0283 (Fax)
For Clinicians:
For Patients:

Supported by educational grants from
EMD Serono
Pfizer Inc.

Related Content

John M. Burke, MD, and Shaji Kumar, MD, discuss practice-changing presentations in lymphomas, CLL, and multiple myeloma from ASCO 2019.

John M. Burke, MD Shaji Kumar, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: August 16, 2019 Expiration: August 15, 2020

Noopur Raje, MD: Clinical impact of latest data for idecabtagene vicleucel (bb2121) and other CAR T-cells in relapsed/refractory multiple myeloma.

Noopur Raje, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: August 16, 2019 Expiration: August 15, 2020

A CME-certified activity with insights on the optimal care of advanced gastric/GEJ cancers using checkpoint inhibitors from Clinical Care Options

Tanios Bekaii-Saab Tanios Bekaii-Saab, MD, FACP Axel Grothey Headshot Axel Grothey, MD Steven Maron, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: August 9, 2019 Expiration: August 8, 2020

This archived CCO symposium Webcast provides expert guidance on the use of immune checkpoint inhibitors in advanced head and neck cancers (HNSCC)

Barbara Ann Burtness, MD
Program Director
Robert L. Ferris, MD, PhD Cristina P. Rodriguez, MD
Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: August 8, 2019 Expiration: August 7, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?